NCT07060365
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07060365
Title A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
Research Site Fullerton California 92835 United States Details
Research Site Albuquerque New Mexico 87109 United States Details
Research Site Oklahoma City Oklahoma 73104 United States Details
Research Site Sioux Falls South Dakota 57105 United States Details
Research Site Seattle Washington 98109 United States Details
Research Site Milan 20159 Italy Details
Research Site Milan 20132 Italy Details
Research Site Milan 20141 Italy Details
Research Site Milan 20162 Italy Details
Research Site Monza 20900 Italy Details
Research Site Ravenna 48100 Italy Details
Research Site Rome 00168 Italy Details
Research Site Goyang 410-769 South Korea Details
Research Site Seoul 03080 South Korea Details
Research Site Seoul 08308 South Korea Details
Research Site Seoul 135-720 South Korea Details
Research Site Barcelona 08028 Spain Details
Research Site Barcelona 8035 Spain Details
Research Site Valencia 46010 Spain Details
Research Site Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field